Catalent
Catalent develops and manufactures drugs, protein-based biologics, cell and gene therapies, and consumer health products.
All edits
Catalent
DeveloperCatalent develops and manufacturer ofmanufactures drugs, protein-based biologics, cell and gene therapies, and consumer health products.
Catalent is a U.S.-basedUS-based company that provides differentiated development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products. The company works with pharma, biotech, and consumer health companies to optimize those companies' product development, launch, and full life-cycle supply globally. Catalent has expertise in development sciences, delivery technologies, and multi-modality manufacturing, helping companies with personalized medicines, consumer health brand extensions, and blockbuster drugs.
Catalent is an S&P 500® company that is publicly traded on the New York Stock Exchange under the symbol CTLT. Alessandro Maselli was appointed as Presidentpresident and CEO in July 2022. The company is headquartered in Somerset, New Jersey, and reported $4 billion in revenue in its 2021 fiscal year. Catalent has over 17,000 employees worldwide, which includes more than 2,500 scientists and technicians.
Catalent is a U.S.-based company that provides differentiated development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products. The company works with pharma, biotech, and consumer health companies to optimize those companies' product development, launch, and full life-cycle supply globally. Catalent has expertise in development sciences, delivery technologies, and multi-modality manufacturing, helping companies with personalized medicines, consumer health brand extensions, and blockbuster drugsdrugs.
Catalent is an S&P 500® company that is publicly traded on the New York Stock Exchange under the symbol CTLT. Alessandro Maselli was appointed as President and CEO in July 2022. The company is headquartered in Somerset, New Jersey,, and reported $4 billion in revenue in its 2021 fiscal year. Catalent has over 17,000 employees worldwide, which includes more than 2,500 scientists and technicians.
Catalent
Developer and manufacturer forof drugs, protein-based biologics, cell and gene therapies, and consumer health products.
Catalent is an S&P 500® company that is publicly traded on the New York Stock Exchange under the symbol CTLT. Alessandro Maselli was appointed as President and CEO inJulyin July 2022. The company is headquartered in Somerset, New Jersey, and reported $4 billion in revenue in its 2021 fiscal year. Catalent has over 17,000 employees worldwide, which includes more than 2,500 scientists and technicians.
Find more companies like Catalent
